Clinical Trial Update: Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

View source ↗

Summary

Clinical trial investigating cardiomyopathy in steroid-resistant nephrotic syndrome associated with focal segmental glomerulosclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Focal Segmental Glomerulosclerosis
• Nephrotic Syndrome
• Steroid-resistant Nephrotic Syndrome

Snippet

Sponsor: Northwell Health | Conditions: Focal Segmental Glomerulosclerosis, Nephrotic Syndrome | Status: TERMINATED